Heart failure drug shows promise for better heart relaxation
NCT ID NCT07157527
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 34 times
Summary
This study looks at whether a medicine called sacubitril/valsartan can improve the heart's ability to relax and fill with blood in people with heart failure with reduced ejection fraction (HFrEF). About 70 adults will take the drug for six months and have ultrasound scans to measure changes. The goal is to see if the drug helps the heart pump and relax better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEFT VENTRICULAR DIASTOLIC FUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.